(Q3)Sep 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 69.44%282.74K | -50.83%15.49K | 10.13%284.84K | 204.73%86.46K | 36.67%166.87K | 0 | 89.79%31.5K | 183.44%258.63K | 412.39%28.37K | 391.22%122.1K |
Operating revenue | 69.44%282.74K | -50.83%15.49K | 10.13%284.84K | 204.73%86.46K | 36.67%166.87K | --0 | 89.79%31.5K | 183.44%258.63K | 412.39%28.37K | 391.22%122.1K |
Cost of revenue | 126.68%110.45K | -67.84%25.17K | -11.69%213.65K | -72.96%29.97K | -2.10%48.73K | 38.59%56.69K | 94.33%78.27K | 20.86%241.95K | -4.03%110.81K | 55.07%49.77K |
Gross profit | 45.83%172.29K | 79.30%-9.68K | 326.58%71.18K | 168.45%56.5K | 63.34%118.15K | -212.10%-56.69K | -97.51%-46.77K | 115.32%16.69K | 33.73%-82.54K | 1,099.05%72.33K |
Operating expense | -38.23%269.01K | -16.57%290.81K | 21.92%1.81M | 23.14%528.85K | 22.08%435.51K | -2.49%497.78K | 85.33%348.56K | 67.13%1.48M | 129.77%429.48K | 19.35%356.74K |
Selling and administrative expenses | -54.53%91.63K | -15.69%149.76K | 17.28%829.33K | 21.86%203.28K | 20.09%201.53K | -21.96%246.9K | 216.58%177.62K | 39.15%707.1K | 188.64%166.82K | -9.12%167.81K |
-General and administrative expense | -54.53%91.63K | -15.69%149.76K | 17.28%829.33K | 21.86%203.28K | 20.09%201.53K | -21.96%246.9K | 216.58%177.62K | 39.15%707.1K | 188.64%166.82K | -9.12%167.81K |
Research and development costs | -21.55%15K | 50.00%15K | -39.08%90.98K | -73.12%15K | -30.13%19.12K | -21.71%46.86K | 58.23%10K | 78.33%149.34K | 165.08%55.8K | 12.96%27.36K |
Depreciation amortization depletion | -35.19%3.64K | -35.80%3.3K | 22.98%24.11K | -45.43%7.65K | 179.09%5.62K | 204.98%5.69K | 202.89%5.14K | 523.81%19.6K | 1,219.19%14.02K | 121.21%2.01K |
-Depreciation and amortization | -35.19%3.64K | -35.80%3.3K | 22.98%24.11K | -45.43%7.65K | 179.09%5.62K | 204.98%5.69K | 202.89%5.14K | 523.81%19.6K | 1,219.19%14.02K | 121.21%2.01K |
Provision for doubtful accounts | -66.01%2.98K | -117.04%-470 | 225.35%81.18K | 1,020.05%74.24K | -6.68%8.76K | -166.82%-4.58K | 32.02%2.76K | --24.95K | --6.63K | 217.06%9.39K |
Other operating expenses | -22.31%155.76K | -19.48%123.22K | 34.40%784.61K | 22.81%228.68K | 33.50%200.48K | 61.62%202.9K | 25.58%153.03K | 99.01%583.79K | 68.14%186.21K | 74.31%150.17K |
Operating profit | 69.53%-96.72K | 23.99%-300.49K | -18.45%-1.74M | 7.75%-472.35K | -11.59%-317.36K | -20.56%-554.47K | -86.69%-395.32K | -47.20%-1.47M | -64.39%-512.02K | 7.10%-284.41K |
Net non-operating interest income (expenses) | -1,821.29%-37.03K | -31.68%2.97K | 11,201.77%12.55K | 747.02%5.12K | 985.19%2.15K | 486.01%938 | 1,978.79%4.34K | 96.33%-113 | 361.47%604 | 85.20%-243 |
Non-operating interest income | 164.89%6.42K | -29.35%3.24K | 1,508.39%13.61K | --5.39K | --2.42K | ---- | --4.58K | --846 | ---- | ---- |
Non-operating interest expense | 15,814.29%43.45K | 12.35%273 | 10.74%1.06K | --273 | --273 | ---- | 5.19%243 | -68.86%959 | ---- | ---- |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | -486.01%-938 | ---- | ---- | ---- | --243 |
Other net income (expenses) | -96.71%2.68K | 220.85%2.9K | 79.35%-38.59K | 50.84%-84.57K | 638.07%81.47K | -2,748.84%-33.08K | -153.49%-2.4K | -3,234.62%-186.89K | -3,999.55%-172.05K | -2,627.71%-15.14K |
Gain on sale of security | -38.92%2.68K | 220.85%2.9K | -140.45%-20.81K | -6,688.46%-14.12K | 150.15%4.39K | -795.28%-8.68K | -153.49%-2.4K | -182.12%-8.66K | -102.31%-208 | -1,560.93%-8.75K |
Special income (charges) | --0 | ---- | 53.22%-83.38K | 65.68%-58.98K | --0 | ---24.4K | ---- | -3,792.33%-178.23K | -3,652.78%-171.84K | ---6.39K |
-Less:Impairment of capital assets | ---- | ---- | 1,372.05%83.38K | ---- | ---- | ---- | ---- | --5.66K | ---- | ---- |
-Less:Write off | --0 | ---- | --0 | -114.68%-24.4K | --0 | --24.4K | ---- | 2,673.48%172.57K | 2,570.78%166.18K | --6.39K |
Other non-operating income (expenses) | ---- | ---- | --65.6K | ---11.48K | --77.08K | ---- | ---- | ---- | ---- | ---- |
Income before tax | 43.93%-131.06K | 25.10%-294.63K | -6.64%-1.77M | 19.26%-551.81K | 22.03%-233.74K | -27.83%-586.62K | -84.74%-393.38K | -66.44%-1.66M | -122.42%-683.46K | 2.40%-299.8K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 43.93%-131.06K | 25.10%-294.63K | -6.64%-1.77M | 19.26%-551.81K | 22.03%-233.74K | -27.83%-586.62K | -84.74%-393.38K | -66.44%-1.66M | -122.42%-683.46K | 2.40%-299.8K |
Net income continuous operations | 43.93%-131.06K | 25.10%-294.63K | -6.64%-1.77M | 19.26%-551.81K | 22.03%-233.74K | -27.83%-586.62K | -84.74%-393.38K | -66.44%-1.66M | -122.42%-683.46K | 2.40%-299.8K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 43.93%-131.06K | 25.11%-294.61K | -6.64%-1.77M | 19.26%-551.81K | 22.03%-233.74K | -27.72%-586.12K | -84.74%-393.38K | -66.44%-1.66M | -122.42%-683.46K | 2.40%-299.81K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 43.93%-131.06K | 25.11%-294.61K | -6.64%-1.77M | 19.26%-551.81K | 22.03%-233.74K | -27.72%-586.12K | -84.74%-393.38K | -66.44%-1.66M | -122.42%-683.46K | 2.40%-299.81K |
Diluted earnings per share | 43.92%-0.0013 | 29.16%-0.003 | 0.00%-0.02 | 0.00%-0.01 | 32.17%-0.0024 | 0.00%-0.01 | -64.03%-0.0043 | -100.00%-0.02 | -0.01 | 14.28%-0.0035 |
Basic earnings per share | 43.92%-0.0013 | 29.16%-0.003 | 0.00%-0.02 | 0.00%-0.01 | 32.17%-0.0024 | 0.00%-0.01 | -64.03%-0.0043 | -100.00%-0.02 | -0.01 | 14.28%-0.0035 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data